Publication Cover
JAPCA Volume 38, 1988 - Issue 1
572
Views
59
CrossRef citations to date
0
Altmetric
Original Articles

Pulmonary Function and Symptom Responses after 6.6-Hour Exposure to 0.12 ppm Ozone with Moderate Exercise

, &
Pages 28-35 | Received 06 Aug 1987, Accepted 01 Oct 1987, Published online: 08 Mar 2012
 

Abstract

Episodes occasionally occur when ambient ozone (O3) levels remain at or near 0.12 ppm for more than 6 h. Small decrements In lung function have been reported following 2-h exposures to 0.12 ppm O3. For short exposures to higher O3 concentrations, lung function decrements are a function of exposure duration. Thus, we investigated the hypothesis that prolonged exposure to 0.12 ppm O3 would result in progressively larger changes in respiratory function and symptoms over time. Ten nonsmoking males (18-33 yr) were exposed once to clean air and once to 0.12 ppm O3 for 6.6 h. Exposures consisted of six 50-min exercise periods, each followed by 10-min rest and measurement; a 35-min lunch period followed the third exercise period. Exercise ventilation averaged approximately 40 L/min. Forced expiratory and inspiratory spirometry and respiratory symptoms were measured prior to exposure and after each exercise. Airway reactivity to methachollne was determined after each exposure. After correcting for the air exposures, FEV1.0 was found to decrease linearly during the O3 exposure and was decreased by an average of 13.0 percent (591 mL) at the end of exposure. Decreases in FVC and FEF25-75 % were also linear and averaged 8.3 and 17.4 percent, respectively, at the end of exposure. On forced Inspiratory tests, the FIVC and FIV05 were decreased 12.6 and 20.7 percent, respectively. Increases in the symptom ratings of cough and pain on deep Inspiration were observed with O3 exposure but not with clean air. Airway reactivity to methacholine was approximately doubled following O3 exposure. We conclude that prolonged exposure to 0.12 ppm O3 results in progressive changes in respiratory function, a marked increase in nonspecific airway reactivity, and progressive changes in symptoms.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.